$FTH
Faeth Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Austin, TX
FTH chart
What traders are saying about $FTH
Latest postsFaeth Therapeutics, Inc. news
- Faeth Therapeutics, Inc. Announces Appointment of Adam Schayowitz as Director
www.marketscreener.com ·
- Faeth Therapeutics Appoints Zymeworks R&D Head Adam Schayowitz to Board of Directors
citybiz ·
- Cantor Fitzgerald reiterates Faeth Therapeutics stock rating By Investing.com
Investing.com India ·
- Form 8K Faeth Therapeutics, Inc For: 27 October By Investing.com
Investing.com Canada ·
- Faeth Therapeutics appoints Adam Schayowitz to board of directors By Investing.com
Investing.com Canada ·
- Faeth Therapeutics appoints Adam Schayowitz to its board
TradingView ·
- Form 8-K Faeth Therapeutics, Inc. For: Oct 23
StreetInsider ·
- Faeth Therapeutics appoints Adam Schayowitz to board By Investing.com
Investing.com Canada ·
- Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
Yahoo Finance ·
- BTIG reiterates Buy rating on Faeth Therapeutics, $55 price target
TradingView ·
- Faeth Therapeutics, Inc. Estimates – NASDAQ:FTH
TradingView ·
- Faeth Therapeutics (FTH) Reports Promising Preclinical Data on P
GuruFocus ·
Faeth Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$21.1M | -$30.2M | -$34.1M | -$48.6M |
| Diluted EPS | $-16.72 | $-24.01 | $-1.22 | $-1.58 |
| Total assets (year end) | $22.9M | $45.4M | $74.4M | $118.4M |
| Cash and equivalents (year end) | $8.7M | $10.0M | $13.0M | $17.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Faeth Therapeutics, Inc.
- Ticker
- FTH (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc.
Frequently asked questions
What exchange is Faeth Therapeutics, Inc. listed on?
Faeth Therapeutics, Inc. trades on the Nasdaq under the ticker symbol FTH.
What industry is Faeth Therapeutics, Inc. in?
Faeth Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Faeth Therapeutics, Inc. headquartered?
Faeth Therapeutics, Inc.'s business address on file with the SEC is in Austin, TX.
When does Faeth Therapeutics, Inc.'s fiscal year end?
Faeth Therapeutics, Inc.'s fiscal year ends on December 31.